Delivery Order SPE2DB22D2211-SPE2DB25FSBLZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,066.50 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This competitive award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $5,499.85 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,520,349 units of the pharmaceutical product Injectafer, a 750 mg/15 mL vial. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, under which AmerisourceBergen provides a comprehensive range of medical commodities to...
- The Defense Logistics Agency awarded a $21,873.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price, competitively awarded contract is scheduled for completion by August 11, 2025, with performance based in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating AmerisourceBergen competed against other vendors to secure this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $20,568.01 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed price, non-set-aside contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine procurement action within AmerisourceBergen's existing...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $17,739.44 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of 4,564,205,201 INJECTAFER 750 MG/15 ML VIAL 15ML, a pharmaceutical product, with a period of performance through April 9, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with DLA, with a potential value of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $11,001.13 award is for the supply of Injectafer 750 mg/15 ml vials, a specialty pharmaceutical product, with a completion date of March 27, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- The Defense Logistics Agency awarded a $21,388.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Injectafer 750 mg/15 mL vials on August 1, 2025, with an ultimate completion date of August 4, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle that runs through December 2026. The order will be fulfilled from the vendor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $15,003.41 firm fixed-price delivery order on August 5, 2025, for the supply of Injectafer 750 mg/15 mL vials. The contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $19,856.34 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $23,521.93. This is a firm fixed-price delivery order with no set-aside designation, demonstrating that the contract was competitively awarded. The ultimate completion date is scheduled for July 21, 2025, and the product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBLZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,239.00 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order represents a continuation of AmerisourceBergen's substantial role as a critical federal medical supplier through the DLA's pharmaceutical procurement network. This delivery order operates as a child contract under AmerisourceBergen's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This overarching contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military and federal healthcare programs worldwide. The parent contract demonstrates the company's established capability to fulfill complex federal medical supply requirements across multiple therapeutic domains and geographic regions, positioning it as a primary vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.2k | 7/24/25 |